This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Stevens RJ et al. (2001) The UKPDS risk engine, a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin Sci 101: 671–679
Anderson KM et al. (1991) Cardiovascular disease risk profiles. Am Heart J 121: 293–298
Coleman RL et al. (2007) Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 30: 1292–1293
Collins R et al. (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361: 2005–2016
Gregg EW et al. (2007) Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147: 149–155
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Adler, A. Patients with diabetes—to whom should one offer statin treatment?. Nat Rev Endocrinol 4, 16–17 (2008). https://doi.org/10.1038/ncpendmet0671
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0671